NRx Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc. - ROEverified

NRXP

Price:

$3.84

Market Cap:

$66.38M

NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative therapies for disorders of the central nervous system and critical lung diseases. Its product portfolio features ZYESAMI, an experimental medication that has successfully completed Phase IIb/III clinical trials for treating respiratory failure associated with COVID-19. Additionally, the company is advancing NRX-100 and NRX-101, a pair of oral therapeutics designed to address bipolar depression, specifically in patients exhibiting acute or sub-acute suicidal thoughts and behaviors. Established in 2015, NRx Pharmaceuticals is headquartered in Wilmington, Delaware.

Industry

Biotechnology

IPO Date

2017-12-04

Stock Exchange

NASDAQ

Ticker

NRXP

The ROE as of July 2026 (TTM) for NRx Pharmaceuticals, Inc. (NRXP) is 107.73%

According to NRx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is 107.73%. This represents a change of 436.46% compared to the average of 20.08% of the last 4 quarters.

NRx Pharmaceuticals, Inc. (NRXP) Historical ROE (quarterly & annually)

How has NRXP ROE performed in the past?

The mean historical ROE of NRx Pharmaceuticals, Inc. over the last ten years is -35.50%. The current 107.73% ROE has changed -403.48% with respect to the historical average. Over the past ten years (40 quarters), NRXP's ROE was at its highest in in the March 2023 quarter at 3.89%. The ROE was at its lowest in in the March 2021 quarter at -2089.19%.

Quarterly (TTM)
Annual

Average

-35.50%

Median

1.38%

Minimum

-536.56%

Maximum

256.97%

NRx Pharmaceuticals, Inc. (NRXP) ROE by Quarter and Year

Discovering the peaks and valleys of NRx Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 8.44%

Maximum Annual ROE = 256.97%

Minimum Annual Increase = -478.13%

Minimum Annual ROE = -536.56%

Quarterly (TTM)
Annual
YearROEChange
2025179.59%65.99%
2024108.19%-57.90%
2023256.97%-147.89%
2022-536.56%19.96%
2021-447.29%-478.13%
2020118.29%8.44%
20191.38%1.36%
20180.10%-162.89%

NRx Pharmaceuticals, Inc. (NRXP) Average ROE

How has NRXP ROE performed in the past?

The current ROE of NRx Pharmaceuticals, Inc. (NRXP) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

181.59%

5-year avg

-87.82%

10-year avg

-35.50%

NRx Pharmaceuticals, Inc. (NRXP) ROE vs. Peers

How is NRXP’s ROE compared to its peers?

NRx Pharmaceuticals, Inc.’s ROE is greater than Cue Biopharma, Inc. (-98.30%), less than Outlook Therapeutics, Inc. (178.08%), greater than Spruce Biosciences, Inc. (-155.40%), greater than Coeptis Therapeutics Holdings, Inc. (-82.93%), greater than Werewolf Therapeutics, Inc. (-208.23%), greater than Equillium, Inc. (-61.43%), less than Karyopharm Therapeutics Inc. (73.11%), greater than IO Biotech, Inc. (-591.35%), greater than Century Therapeutics, Inc. (-53.23%), greater than Senti Biosciences, Inc. (-503.79%),

Build a custom stock screener for NRx Pharmaceuticals, Inc. (NRXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NRx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NRx Pharmaceuticals, Inc. (NRXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NRx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is NRx Pharmaceuticals, Inc.'s ROE?

How is the ROE calculated for NRx Pharmaceuticals, Inc. (NRXP)?

What is the highest ROE for NRx Pharmaceuticals, Inc. (NRXP)?

What is the 3-year average ROE for NRx Pharmaceuticals, Inc. (NRXP)?

What is the 5-year average ROE for NRx Pharmaceuticals, Inc. (NRXP)?

How does the current ROE for NRx Pharmaceuticals, Inc. (NRXP) compare to its historical average?